• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国新乡地区代谢相关脂肪性肝病的流行状况及其危险因素分析。

Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China.

机构信息

School of Public Health, Xinxiang Medical University, Xinxiang 453003, Henan, China.

School of Management, Xinxiang Medical University, Xinxiang 453003, Henan, China.

出版信息

Int J Environ Res Public Health. 2020 Mar 11;17(6):1818. doi: 10.3390/ijerph17061818.

DOI:10.3390/ijerph17061818
PMID:32168920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7143027/
Abstract

Metabolic associated fatty liver disease (MAFLD) is recognized as the liver disease component of metabolic syndrome, which is mainly related to insulin resistance and genetic susceptibility. It is the most prevalent chronic liver disease worldwide. With rapid lifestyle transitions, its prevalence worldwide is increasing, and tremendous challenges in controlling this pandemic are arising. The objective of this study was to investigate the prevalence and risk factors of MAFLD in rural areas of Xinxiang, Henan in 2017. We conducted a cross-sectional analysis of rural inhabitants aged 20-79 years in Xinxiang, Henan in 2017, using cluster random sampling ( = 9140). Physical examinations were conducted at local clinics from April to June 2017. After overnight fasting, all participants underwent physical examinations, blood routine tests, biochemical examinations, and liver ultrasound and completed questionnaires. We investigated the crude and age-adjusted MAFLD prevalence and analyzed the characteristics of those with, and without, MAFLD, using logistic regression. Approximately 2868 (31.38%) participants were diagnosed with MAFLD. The overall age-adjusted MAFLD prevalence was 29.85% (men: 35.36%; women: 26.49%). The MAFLD prevalence increased with age, and peaked at the 50-59-year age group, and then began to decline. Higher body mass index, waist circumference, percentage of lymphocytes, levels of hemoglobin, platelet count, triglyceride, fasting plasma glucose, and serum uric acid were independently and positively correlated with MAFLD; In contrary, active physical activity and high-density lipoprotein cholesterol were negatively correlated with MAFLD. In summary, the MAFLD prevalence in the study population was 29.85%. Higher body mass index, waist circumference, percentage of lymphocytes, levels of hemoglobin, platelet count, triglyceride, fasting plasma glucose, and serum uric acid were risk factors for MAFLD.

摘要

代谢相关性脂肪性肝病(MAFLD)被认为是代谢综合征的肝脏疾病组分,主要与胰岛素抵抗和遗传易感性相关。它是全球最普遍的慢性肝脏疾病。随着生活方式的快速转变,其在全球的患病率正在增加,控制这一流行疾病的巨大挑战正在出现。本研究旨在调查 2017 年河南新乡农村地区 MAFLD 的患病率及其危险因素。我们采用整群随机抽样方法(=9140),对 2017 年河南新乡年龄在 20-79 岁的农村居民进行了横断面分析。2017 年 4 月至 6 月在当地诊所进行体格检查。所有参与者均空腹过夜后进行体格检查、血常规检查、生化检查、肝脏超声检查,并完成问卷调查。我们调查了 MAFLD 的粗患病率和年龄调整后患病率,并使用逻辑回归分析了 MAFLD 患者和非 MAFLD 患者的特征。约 2868(31.38%)名参与者被诊断为 MAFLD。总体年龄调整后 MAFLD 的患病率为 29.85%(男性:35.36%;女性:26.49%)。MAFLD 的患病率随年龄增长而增加,在 50-59 岁年龄组达到峰值,然后开始下降。较高的体质指数、腰围、淋巴细胞百分比、血红蛋白、血小板计数、三酰甘油、空腹血糖和血清尿酸水平与 MAFLD 独立正相关;相反,积极的体育活动和高密度脂蛋白胆固醇与 MAFLD 呈负相关。总之,研究人群中 MAFLD 的患病率为 29.85%。较高的体质指数、腰围、淋巴细胞百分比、血红蛋白、血小板计数、三酰甘油、空腹血糖和血清尿酸水平是 MAFLD 的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0910/7143027/2841efe06060/ijerph-17-01818-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0910/7143027/2841efe06060/ijerph-17-01818-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0910/7143027/2841efe06060/ijerph-17-01818-g001.jpg

相似文献

1
Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China.中国新乡地区代谢相关脂肪性肝病的流行状况及其危险因素分析。
Int J Environ Res Public Health. 2020 Mar 11;17(6):1818. doi: 10.3390/ijerph17061818.
2
Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.中国城市人群代谢相关脂肪性肝病的流行情况及其危险因素:一项横断面对比研究。
BMC Gastroenterol. 2021 May 10;21(1):212. doi: 10.1186/s12876-021-01782-w.
3
Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.基于受控衰减参数的瞬时弹性成像技术诊断 HIV 阳性人群代谢相关脂肪性肝病的流行情况及其影响因素。
Int J STD AIDS. 2021 Mar;32(3):266-275. doi: 10.1177/0956462420960997. Epub 2020 Dec 18.
4
The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults: a population-based study.甘油三酯-葡萄糖-腰围与代谢相关脂肪性肝病及其严重程度的相关性:一项基于人群的美国成年人研究。
Scand J Gastroenterol. 2024 May;59(5):561-569. doi: 10.1080/00365521.2024.2305268. Epub 2024 Jan 18.
5
[Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].[体检人群中代谢功能障碍相关脂肪性肝病风险预测模型的建立与分析]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 May;54(3):591-595. doi: 10.12182/20230560109.
6
[Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].[上海普通成年人群脂肪肝患病率及其危险因素的流行病学调查]
Zhonghua Gan Zang Bing Za Zhi. 2005 Feb;13(2):83-8.
7
Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.腰围、体重指数、血清尿酸、血糖和甘油三酯水平是台湾人群肝功能异常的重要危险因素。
Kaohsiung J Med Sci. 2012 Sep;28(9):470-6. doi: 10.1016/j.kjms.2012.04.003. Epub 2012 Jul 7.
8
Prevalence of fatty liver disease and its risk factors in the population of South China.中国南方人群中脂肪肝疾病的患病率及其风险因素
World J Gastroenterol. 2007 Dec 21;13(47):6419-24. doi: 10.3748/wjg.v13.i47.6419.
9
A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups.四种特殊中国成年人群腰围、体质指数与收缩压和舒张压的比较和关联,以及临床实验室数据与肥胖高血压的对比研究。
Clin Exp Hypertens. 2018;40(1):16-21. doi: 10.1080/10641963.2017.1281940. Epub 2017 Oct 30.
10
Prevalence and risk factors of fatty liver disease in young and middle-aged population: one center study in Southwestern China.中青年人群脂肪肝疾病的患病率及危险因素:中国西南地区一项单中心研究
J Gastroenterol Hepatol. 2014 Feb;29(2):358-64. doi: 10.1111/jgh.12334.

引用本文的文献

1
Multiomics reveals metformin's dual role in gut microbiome remodeling and hepatic metabolic reprogramming for MAFLD intervention.多组学揭示二甲双胍在肠道微生物群重塑和肝脏代谢重编程以干预非酒精性脂肪性肝病中的双重作用。
Sci Rep. 2025 Jul 2;15(1):22699. doi: 10.1038/s41598-025-07557-7.
2
Multifaceted environmental factors linked to metabolic dysfunction-associated fatty liver disease: an environment-wide association study.与代谢功能障碍相关脂肪性肝病相关的多方面环境因素:一项全环境关联研究
BMC Public Health. 2025 Feb 20;25(1):709. doi: 10.1186/s12889-025-21930-1.
3
Association Between Serum Uric Acid Levels and Metabolic-Associated Fatty Liver Disease in Southeast China: A Cross-Sectional Study.

本文引用的文献

1
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD:代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
2
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology.遗传因素对非酒精性脂肪性肝病的影响:利用共同遗传学揭示系统生物学。
Nat Rev Gastroenterol Hepatol. 2020 Jan;17(1):40-52. doi: 10.1038/s41575-019-0212-0. Epub 2019 Oct 22.
3
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation.
中国东南部地区血清尿酸水平与代谢相关脂肪性肝病的关联:一项横断面研究
Diabetes Metab Syndr Obes. 2024 Sep 7;17:3343-3354. doi: 10.2147/DMSO.S476045. eCollection 2024.
4
High-density lipoprotein cholesterol trajectory and new-onset metabolic dysfunction-associated fatty liver disease incidence: a longitudinal study.高密度脂蛋白胆固醇轨迹与新发代谢功能障碍相关脂肪性肝病发病率:一项纵向研究。
Diabetol Metab Syndr. 2024 Sep 11;16(1):223. doi: 10.1186/s13098-024-01457-y.
5
Predictive Value of the Chinese Visceral Adiposity Index for Metabolic Dysfunction-Associated Fatty Liver Disease and Elevated Alanine Aminotransferase Levels in Nonobese Chinese Adults: A Cross-Sectional Study.中国内脏脂肪素指数对非肥胖中国成年人代谢功能障碍相关脂肪性肝病及丙氨酸氨基转移酶水平升高的预测价值:一项横断面研究
J Inflamm Res. 2024 Jun 18;17:3893-3913. doi: 10.2147/JIR.S468093. eCollection 2024.
6
Elevated Kallistatin promotes the occurrence and progression of non-alcoholic fatty liver disease.升高的 Kallistatin 促进非酒精性脂肪性肝病的发生和进展。
Signal Transduct Target Ther. 2024 Mar 12;9(1):66. doi: 10.1038/s41392-024-01781-9.
7
Relationship between skeletal muscle mass loss and metabolic dysfunction-associated fatty liver disease among Chinese patients with metabolic dysregulation.代谢失调中国患者骨骼肌质量损失与代谢功能相关脂肪性肝病的关系。
Rev Assoc Med Bras (1992). 2024 Mar 4;70(3):e20230963. doi: 10.1590/1806-9282.20230963. eCollection 2024.
8
The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD.2型糖尿病合并MAFLD患者中晚期肝纤维化与骨质疏松症的关系。
Endocrine. 2024 Jul;85(1):206-221. doi: 10.1007/s12020-024-03724-4. Epub 2024 Feb 17.
9
Clustering of lifestyle behaviours and analysis of their associations with MAFLD: a cross-sectional study of 196,515 individuals in China.生活方式行为聚类及其与 MAFLD 相关性分析:中国 196515 例个体的横断面研究。
BMC Public Health. 2023 Nov 21;23(1):2303. doi: 10.1186/s12889-023-17177-3.
10
Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study.从非酒精性脂肪性肝病(NAFLD)到代谢相关性脂肪性肝病(MAFLD):基于人群的横断面研究中患病率和系统性炎症水平的变化。
Lipids Health Dis. 2023 Oct 28;22(1):185. doi: 10.1186/s12944-023-01947-4.
瘦型非酒精性脂肪性肝病:一种由不同代谢适应塑造的独特实体。
Hepatology. 2020 Apr;71(4):1213-1227. doi: 10.1002/hep.30908. Epub 2020 Jan 24.
4
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.亚洲地区非酒精性脂肪性肝病的流行率、发病率和结局:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1. Epub 2019 Mar 20.
5
Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects.肥胖与非肥胖受试者粪便和血液微生物群特征及非酒精性脂肪性肝病的存在。
PLoS One. 2019 Mar 14;14(3):e0213692. doi: 10.1371/journal.pone.0213692. eCollection 2019.
6
Genetics of Nonalcoholic Fatty Liver Disease: A 2018 Update.非酒精性脂肪性肝病的遗传学:2018 年更新。
Curr Pharm Des. 2018;24(38):4566-4573. doi: 10.2174/1381612825666190119113836.
7
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity.代谢状态对非酒精性脂肪性肝病相关结局的影响,超出了肥胖的存在。
Aliment Pharmacol Ther. 2018 Dec;48(11-12):1260-1270. doi: 10.1111/apt.15015. Epub 2018 Oct 23.
8
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.全球视角下的非酒精性脂肪性肝病和非酒精性脂肪性肝炎。
Hepatology. 2019 Jun;69(6):2672-2682. doi: 10.1002/hep.30251.
9
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.建立中国、法国、德国、意大利、日本、西班牙、英国和美国 2016-2030 年非酒精性脂肪性肝病疾病负担模型。
J Hepatol. 2018 Oct;69(4):896-904. doi: 10.1016/j.jhep.2018.05.036. Epub 2018 Jun 8.
10
[Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update].非酒精性脂肪性肝病防治指南:2018年更新版
Zhonghua Gan Zang Bing Za Zhi. 2018 Mar 20;26(3):195-203. doi: 10.3760/cma.j.issn.1007-3418.2018.03.008.